| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |